Tiago Torres

Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study

Satveer K. Mahil, Nick Dand, K.J. Mason et al. · Journal of Allergy and Clinical Immunology · 2020 · 158 citations · Full text

Adverse Covid-19 Outcomes, Global Health, Covid-19 Pandemic +9

Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19

Zara Izadi, Erica J. Brenner, Satveer K. Mahil et al. · JAMA Network Open · 2021 · 114 citations · Full text

Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study

Tiago Torres, L. Puig, Ronald Vender et al. · American Journal of Clinical Dermatology · 2021 · 112 citations · Full text

Il-23 Inhibitors, Medicine, Drug Survival +6

The Protective Role of HLA-DRB1<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"/>13 in Autoimmune Diseases

Andreia Bettencourt, Cláudia Carvalho, Bárbara Leal et al. · Journal of Immunology Research · 2015 · 90 citations · Full text

Hla, Histocompatibility, Immunodeficiencies +30

Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort Study

Tiago Torres, L. Puig, Ronald Vender et al. · American Journal of Clinical Dermatology · 2022 · 73 citations · Full text

Inflammation, Drug Survival, Immunology +7